Intuitive Surgical (ISRG) Non-Current Assets (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Non-Current Assets came in at $11.3 billion in Q2 2026, down 0.73% year-on-year from $11.4 billion in Q2 2025, and little changed quarter-over-quarter from $11.3 billion in Q1 2026.
Intuitive Surgical (ISRG) Non-Current Assets (2009 - 2026) Analysis & Trends
Intuitive Surgical's Non-Current Assets history runs 18 years deep, the most recent figure standing at $11.3 billion for Q2 2026.
- On a quarterly basis, Non-Current Assets fell 0.73% year-over-year to $11.3 billion in Q2 2026; TTM through Jun 2026 was $44.1 billion, a 2.21% decrease from a year earlier, with the FY2025 full-year figure at $10.7 billion, down 8.19% from the prior year.
- Non-Current Assets steadied at $11.3 billion in Q2 2026 per ISRG's latest filing, from $11.3 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $11.6 billion in Q4 2024 and bottomed at $5.8 billion in Q3 2023.
- The 5-year median for Non-Current Assets is $8.6 billion (2024), against an average of $8.9 billion.
- Across the five-year window, Non-Current Assets decreased 21.57% in 2023 and surged 81.21% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $6.7 billion in 2022, then advanced by 12.39% to $7.6 billion in 2023, then jumped by 54.0% to $11.6 billion in 2024, then slipped by 8.19% to $10.7 billion in 2025, then advanced by 6.13% to $11.3 billion in 2026.
- Per Business Quant, the three latest ISRG Non-Current Assets figures stand at $11.3 billion (Q2 2026), $11.3 billion (Q1 2026), and $10.7 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 13.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.33 Bn |
| Mar 31, 2026 | 11.30 Bn |
| Dec 31, 2025 | 10.68 Bn |
| Sep 30, 2025 | 10.83 Bn |
| Jun 30, 2025 | 11.42 Bn |
| Mar 31, 2025 | 11.56 Bn |
| Dec 31, 2024 | 11.63 Bn |
| Sep 30, 2024 | 10.53 Bn |
| Jun 30, 2024 | 9.00 Bn |
| Mar 31, 2024 | 8.20 Bn |
| Dec 31, 2023 | 7.55 Bn |
| Sep 30, 2023 | 5.81 Bn |
| Jun 30, 2023 | 5.87 Bn |
| Mar 31, 2023 | 6.18 Bn |
| Dec 31, 2022 | 6.72 Bn |
| Sep 30, 2022 | 6.97 Bn |
| Jun 30, 2022 | 7.41 Bn |
| Mar 31, 2022 | 7.88 Bn |
| Dec 31, 2021 | 7.71 Bn |
| Sep 30, 2021 | 7.21 Bn |